Enveric Biosciences, Inc. (ENVB) Free cash flow 2021–2023
Enveric Biosciences, Inc. (ENVB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$14.1MFY2023 · since FY2021: -$11.6M → -$14.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$14.1M | +20.5% |
| FY2022 | -$17.7M | -52.2% |
| FY2021 | -$11.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice